BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2019
View Archived Issues
Too much of a good thing foils heart repair
Read More
Voxelotor improves anemia in adolescents with sickle cell disease
Read More
Plasma kallikrein inhibitor VE-4840 shows preclinical potential for treating diabetic retinopathy
Read More
Long non-coding RNA CASC9 has an oncogenic role in breast cancer
Read More
IMVT-1401 demonstrates promising safety, PK and PD in healthy subjects
Read More
Flavonoid promotes pleiotropic neuroprotective effects
Read More
CAR fusion proteins targeting Strep-tagged peptides patented by Fred Hutchinson, TUM
Read More
Updated data presented from phase Ib/II study of RG-6206 in boys with DMD
Read More
WuXi Biologics describes new bispecific antibodies against EGFR and PD-1
Read More
Novel biomarkers of clinical efficacy of bevacizumab in the treatment of gastric cancer
Read More
NB-01 leads to statistically significant improvements in diabetic neuropathic pain
Read More
TRAF2 and NCK-interacting protein kinase inhibitors discovered at Silverback Therapeutics
Read More
Ajinomoto identifies new sweet receptor antagonists
Read More
Exosomal PD-L1 identified as a cancer therapeutic target
Read More
Blueprint Medicines discloses activin receptor type-1 inhibitors
Read More
ORIC Pharmaceuticals initiates phase Ib study of ORIC-101 in advanced solid tumors
Read More
Promising topline results announced from phase IIb study of seltorexant in major depressive disorder
Read More
Oncolytic adenovirus with specificity for ARMS cells presented
Read More
FDA approves Eylea to treat all stages of diabetic retinopathy
Read More
NIH grant supports Ichor's development of antibodies against hantavirus infections
Read More
DSMB 36-month review of phase III RESOLVE-IT trial of elafibranor in NASH recommends continuation
Read More
Mitochondrial DNA polymorphism linked to infant bronchopulmonary dysplasia
Read More
P-MUC1C-101 shows robust antitumor effects in orthotopic breast tumor model
Read More
Sevuparin fails to show meaningful benefit in phase II trial to manage VOC in sickle cell disease
Read More
Confirmatory phase III trial of dasiglucagon in severe hypoglycemia meets primary endpoint
Read More
